Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • MARCH 2021 Issue has been successfully launched on 1 March 2021.



Ammu A.*, Babitha Annie Eapen, Chaithra S., S. Hemalatha, T. Sivakumar


Vilazodone is reported to cause wide range of adverse drug effects such as dizziness, dry mouth, fatigue, abnormal dreams, decreased libido, arthralgia and palpitation. Despite these well-known side effects we report a 36 year old female patient presented with rash while she was on the treatment with oral vilazodone at 40mg once daily since 1 week. Based on the dermatological examination, her condition was diagnosed as vilazodone induced rash. The symptoms improved after the cessation of offending agent and an alternative antidepressant was prescribed.

Keywords: Rash, Major depressive disorder, Vilazodone.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More